Other · 22 Jul 2016
EditorialPublished 2012
The Outlook of Belimumab in the Treatment of Systemic Lupus Erythematosus
Subjects
Pharmaceutical SciencesSimilar by topic
Review article · 8 Jul 2016
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Commentary · Aug 2010
Belimumab for the treatment of systemic lupus erythematosus
Review article · 2020
The Molecular Mechanism of Corticosteroids for Systemic Lupus Erythematosus Patient?s Treatment and Its Adverse Effects
Editorial · Aug 2011
Belimumab: the first US FDA approved biological therapy for systemic lupus erythematosus
More from this journal
The newest in Journal of Developing Drugs.
Research article · 17 Jul 2026
Effects of a Food-Derived GLP-1 Formula on Endogenous GLP-1 Secretion and Appetite Responses: A Randomized Double-Blind Crossover Study
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Chi-Chiu Mok”

